CD55 Antikörper (Domain SCR4) (FITC)
Kurzübersicht für CD55 Antikörper (Domain SCR4) (FITC) (ABIN231891)
Target
Alle CD55 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- Domain SCR4
-
Spezifität
- Recognizes an epitope in SCR4 domain of CD55 (Decay accelerating factor, DAF), a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein. CD55 is widely expressed on hematopoietic and on many non-hematopoietic cells, it is weakly present on NK cells.
-
Aufreinigung
- Gel filtration
-
Immunogen
-
HPB-ALL human T cell line.
Type of Immunogen: Cells -
Isotyp
- IgM
-
-
-
-
Applikationshinweise
-
Approved: Flo
Usage: The reagent is designed for Flow Cytometry analysis of human blood cells using 20 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 15 mM sodium azide, 0.2 % high-grade protease free BSA as a stabilizing agent.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Andere Bezeichnung
- CD55
-
Hintergrund
-
Name/Gene ID: CD55
Synonyms: CD55, CD55 antigen, Decay-accelerating factor, TC, CR, CROM, DAF -
Gen-ID
- 1604
-
UniProt
- P08174
-
Pathways
- Komplementsystem, Regulation of Leukocyte Mediated Immunity
Target
-